CADUET ® 5/80

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

AMLODIPINE AS BESYLATE 5 MG; ATORVASTATIN AS CALCIUM 80 MG

Disponible desde:

PFIZER PHARMACEUTICALS ISRAEL LTD

Código ATC:

C08CA01

formulario farmacéutico:

FILM COATED TABLETS

Vía de administración:

PER OS

Fabricado por:

PFIZER MANUFACTURING DEUTSCHLAND GMBH, GERMANY

Grupo terapéutico:

AMLODIPINE

indicaciones terapéuticas:

Caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. Amlodipine: - Hypertension - Chronic stable angina - Vasospastic angina (Prinzmetal's or variant angina). Atorvastatin : - Prevention of cardiovascular disease - Heterozygous familial and nonfamilial hypercholesterolemia - Elevated serum TG levels - Primary dysbetalipoproteinemia - Homozygous familial hypercholesterolemia - Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. LDL-C remains >or = 190 mg/dl or 2. LDL-C remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the pediatric patient.

Fecha de autorización:

2011-08-01